Nuvation Bio (NUVB) Enterprise Value (2023 - 2025)
Historic Enterprise Value for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$549.0 million.
- Nuvation Bio's Enterprise Value rose 1.64% to -$549.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$549.0 million, marking a year-over-year increase of 1.64%. This contributed to the annual value of -$502.7 million for FY2024, which is 1775.5% up from last year.
- Latest data reveals that Nuvation Bio reported Enterprise Value of -$549.0 million as of Q3 2025, which was up 1.64% from -$607.7 million recorded in Q2 2025.
- Nuvation Bio's 5-year Enterprise Value high stood at -$461.7 million for Q1 2025, and its period low was -$646.6 million during Q1 2023.
- Over the past 3 years, Nuvation Bio's median Enterprise Value value was -$597.0 million (recorded in 2024), while the average stood at -$577.5 million.
- Data for Nuvation Bio's Enterprise Value shows a peak YoY increase of 2266.42% (in 2025) and a maximum YoY decrease of 529.36% (in 2025) over the last 5 years.
- Nuvation Bio's Enterprise Value (Quarter) stood at -$611.2 million in 2023, then rose by 17.76% to -$502.7 million in 2024, then dropped by 9.22% to -$549.0 million in 2025.
- Its Enterprise Value was -$549.0 million in Q3 2025, compared to -$607.7 million in Q2 2025 and -$461.7 million in Q1 2025.